We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

This study is currently recruiting participants.
Verified September 2017 by Henning Willers, M.D., Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT02314364
First Posted: December 11, 2014
Last Update Posted: September 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Henning Willers, M.D., Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2021
  Estimated Primary Completion Date: November 2021 (Final data collection date for primary outcome measure)